Primary record
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one1-[(3R)-3-[4-AMino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyriMidin-1-yl]
- 库存
- 1,982 克
- 纯度
- 99.1 %
- CAS
- 936563-87-0
化合物标识与属性
- CAS
- 936563-87-0
- PubChem CID
- 16126651
- SMILES
- C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
- Canonical SMILES
- C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
名称与同义词
- Ibrutinib
- Ibrutinib Racemate
- PCI-32765 Racemate
- Ibrutinib D5
- PCI-32765 (Racemate)
- (S)-Ibrutinib
- Ibrutinib (Racemate)
- 936563-87-0
- IMBRUVICA
- PCI-32765
- 936563-96-1
- PCI32765 Racemate
- PCI-32765 (Ibrutinib)
- IBRUTINIB IMPURITY 88
- UNII-1X70OSD4VX
- C25H24N6O2
- cc-214
- SCHEMBL201642
- BDBM1773
- CHEMBL3182647
- PCI32765
- SCHEMBL16494959
- CHEBI:91397
- CTK8F8347
- SYN1171
- XYFPWWZEPKGCCK-UHFFFAOYSA-N
- BCPP000127
- HMS3295G01
- HMS3656P11
- HMS3749K05
- HMS3750C19
- HMS5081P13
- BCP02558
- BCP24087
- Bruton's Tyrosine Kinase Inhibitor III
- DMC97717
- LMB56387
- EBC-44150
- HY-10997A
- MFCD12032093
- NSC761910
- PCI 32765
- RW4153
- s2680
- AKOS026750227
- BCP9001055
- CCG-264978
- CS-2438
- EX-5965
- NSC-761910
- RL05884
- SB14736
- SDCCGSBI-0647574.P002
- NCGC00387861-02
- NCGC00387861-03
- AK133084
- AS-16305
- BC638848
- DB-049805
- DB-079642
- FT-0696693
- FT-0721194
- C16762
- G87616
- US8476284, 4
- US8497277, 4
- AB01565866_02
- US8497277, 13
- 1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- A917174
- BRD-A35869383-001-01-9
- Q27163257
- (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- Z2235801928
- Ibrutinib Racemate;PCI32765 Racemate;PCI 32765 Racemate
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
- 1553977-17-5
- 936563-96-1 pound not PCI32765 pound not PCI 32765
- 936563-97-2
- 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-(3-(4-Amino-3-(4-phenyloxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-{3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one
- 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1yl)prop-2-en-1-one
- 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one1-[(3R)-3-[4-AMino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyriMidin-1-yl]
- 1-[(3R)-3-[4-amino-3-[4-(2,3,4,5,6-pentadeuteriophenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-[(3S)-3-[4-AMINO-3-(4-PHENOXYPHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDIN-1-YL]PROP-2-EN-1-ONE
- 1-[3-[4-amino-3-(4-phenoxyphenyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinyl]-2-propen-1-one
- 1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- 1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one
- IbrutinibPCI-32765Imbruvica(R)(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
- PCI-32765; 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
- piperidin-1-yl]prop-2-en-1-one1-{3-[4-AMino-3-(4-phenoxy-phenyl)-pyrazolo[3,4-d]pyriMidin-1-yl]-piperidin-1-yl}-propenone